- Home »
- Quarterly Results »
- Zota Health Care Q1 Results Revenue Surges to ₹56.30 Crores Net Loss Widens to ₹12.72 Crores
Zota Health Care Q1 Results Revenue Surges to ₹56.30 Crores Net Loss Widens to ₹12.72 Crores
Zota Health Care Q1 results show a 13.43% QoQ revenue increase to ₹56.30 crores and a 45.67% YoY rise and despite higher expenses, the company's operating loss worsened to ₹9.28 crores.
by Priyanka P
Updated Sep 05, 2024
Article continues below advertisement
Table of Content
Zota Health Care Growth Comparison
Zota Health Care Q1 Results: In the first quarter of the fiscal year ending June 2024, Zota Health Care reported a total revenue of ₹56.30 crores, reflecting a 13.43% increase from the previous quarter and a notable 45.67% rise compared to the same period last year.
Despite this revenue growth, the company's financial performance was marred by significant increases in expenses. Selling, general, and administrative expenses surged by 34.12% from the previous quarter and 253.48% from the previous year.
Depreciation and amortization costs also rose sharply by 18.02% quarter-over-quarter and 135.44% year-over-year. Other operating expenses saw a decrease of 7.67% from the previous quarter but increased by 64.77% from last year.
Overall operating expenses jumped by 13.24% from the last quarter and 60.83% from the previous year, contributing to an operating loss of ₹9.28 crores, a significant decline from the prior quarter’s loss and the same quarter last year.
The net income before taxes was a loss of ₹12.16 crores, reflecting a worsening financial position compared to previous periods. The net income was a loss of ₹12.72 crores, up substantially from earlier losses.
Consequently, the diluted normalized earnings per share (EPS) fell to ₹4.80, highlighting the company’s deteriorating profitability despite increased revenue. Overall, while revenue grew, rising costs and losses indicate financial difficulties for Zota Health Care.
Here's the information presented in a simple table format:
| Metric | Jun 24 | Mar 23 | QoQ Change | Jun 23 | YoY Change |
|---|---|---|---|---|---|
| Total Revenue | 56.30 | 36.85 | 13.43% | 38.65 | 45.67% |
| Selling/General/Admin Expenses Total | 16.25 | 4.50 | 34.12% | 4.60 | 253.48% |
| Depreciation/Amortization | 8.02 | 3.88 | 18.02% | 3.41 | 135.44% |
| Other Operating Expenses Total | 14.97 | 10.63 | -7.67% | 9.09 | 64.77% |
| Total Operating Expense | 65.58 | 39.15 | 13.24% | 40.78 | 60.83% |
| Operating Income | -9.28 | -2.31 | 12.14% | -2.13 | 335.97% |
| Net Income Before Taxes | -12.16 | -3.09 | 28.00% | -2.81 | 332.87% |
| Net Income | -12.72 | -2.63 | 84.10% | -2.84 | 348.37% |
| Diluted Normalized EPS | -4.80 | -1.18 | 79.10% | -1.13 | 324.78% |
Source: Here
For More Q1 Results check our Twitter Page
Visit our website for more Q1 results
Zota Health Care Q1 Results
Zota Healthcare financial results for the quarter ending June 30, 2024, show strong year-over-year (YoY) and quarter-on-quarter (QoQ) growth. The company generated ₹5220.36 lakh in revenue from operations, reflecting a significant YoY increase from ₹3525.07 lakh in the same quarter of 2023, though it is slightly lower on a QoQ basis compared to ₹4794.96 lakh in the previous quarter (March 2024). Additionally, Zota Healthcare earned ₹46.85 lakh from other income, contributing to their overall performance.
In terms of expenses, the company spent ₹5035.03 lakh on raw materials, stock purchases, employee benefits, and other operational costs. This represents a notable rise YoY from ₹3523.28 lakh in June 2023 and an increase QoQ from ₹4787.71 lakh in the March 2024 quarter. Despite these rising expenses, the company's profit before tax reached ₹232.21 lakh for the June 2024 quarter, which is a substantial improvement both YoY from ₹37.34 lakh and QoQ from ₹15.62 lakh. After accounting for taxes of ₹64.21 lakh, the final profit stood at ₹158.43 lakh for this period.
Looking at the company's total comprehensive income, Zota Healthcare achieved ₹166.37 lakh in the June 2024 quarter, marking an impressive YoY growth from ₹6.00 lakh in the June 2023 quarter. This improvement was also observed QoQ, compared to ₹24.33 lakh in the previous quarter. Furthermore, the company's share capital amounted to ₹2633.43 lakh, and its earnings per share (EPS) saw a YoY increase to ₹0.60 from ₹0.08 in the same period last year, showcasing strong financial performance both YoY and QoQ.
Zota Healthcare experienced robust growth across key financial metrics, with significant year-over-year and quarter-on-quarter improvements in revenue, profit, and earnings per share.
Here's the information presented in a simple table format:
|
Particulars |
30-06-2024 (Unaudited) |
31-03-2024 (Audited) |
30-06-2023 (Unaudited) |
31-03-2024 (Audited, Year Ended) |
|
I. Revenue from Operations |
5220.36 |
4794.96 |
3525.07 |
16658.50 |
|
II. Other Income |
46.85 |
63.88 |
35.55 |
205.19 |
|
III. Total Income |
5267.21 |
4858.83 |
3560.62 |
16863.69 |
|
IV. Expenses |
||||
|
Cost of Materials Consumed |
2791.11 |
2935.75 |
2629.69 |
12747.46 |
|
Purchase of Stock-in-Trade |
2346.88 |
1565.29 |
1988.19 |
9520.35 |
|
Changes in Inventories of Finished Goods, WIP & SIT |
(560.32) |
(1063.65) |
174.12 |
(1531.53) |
|
Employee Benefit Expenses |
644.17 |
613.12 |
377.55 |
1997.46 |
|
Finance Costs |
64.17 |
64.42 |
52.47 |
186.38 |
|
Depreciation & Amortization |
61.64 |
88.58 |
45.06 |
300.73 |
|
Other Expenses |
1097.29 |
1278.83 |
710.99 |
3593.27 |
|
Total Expenses |
5035.03 |
4787.71 |
3523.28 |
16913.37 |
|
V. Profit Before Exceptional Items & Tax |
232.21 |
15.62 |
37.34 |
490.31 |
|
VI. Exceptional Items |
- |
- |
- |
- |
|
VII. Profit Before Tax |
232.21 |
15.62 |
37.34 |
490.31 |
|
VIII. Tax Expense |
64.21 |
14.04 |
12.96 |
153.78 |
|
Current Tax |
64.21 |
14.04 |
12.96 |
153.78 |
|
Deferred Tax |
(0.97) |
20.74 |
(11.17) |
(0.28) |
|
IX. Profit for the Period from Continuing Operations |
158.43 |
22.33 |
21.22 |
337.59 |
|
X. Profit/Loss from Discontinued Operations |
- |
- |
- |
- |
|
XI. Tax Expense of Discontinued Operations |
- |
- |
- |
- |
|
XII. Profit/Loss from Discontinued Operations (After Tax) |
- |
- |
- |
- |
|
XIII. Profit for the Period |
158.43 |
22.33 |
21.22 |
337.59 |
|
XIV. Other Comprehensive Income |
||||
|
Items that will not be reclassified to P&L |
7.94 |
2.00 |
(15.22) |
14.83 |
|
Income Tax relating to these items |
- |
- |
- |
- |
|
Total Comprehensive Income for the Period |
166.37 |
24.33 |
6.00 |
352.42 |
|
XV. Paid-up Equity Share Capital (Face value `10/share) |
2633.43 |
2584.73 |
2516.48 |
2584.73 |
|
XVI. Earnings per Share (Basic & Diluted) |
0.60 |
0.09 |
0.08 |
Zota Health Care Stock Performance
The table shows key financial details for a company's stock. The market capitalization is ₹1,837 crores, indicating the total market value of all its shares. The current stock price is ₹692, with a high of ₹725 and a low of ₹372 over a period. The book value of the stock is ₹34.8 per share, and the dividend yield is 0.15%, showing the return on investment from dividends. The Return on Capital Employed (ROCE) is -7.32%, and the Return on Equity (ROE) is -16.8%, both negative, indicating financial challenges. The face value of each share is ₹10.
Here is the financial summary in table format:
(Rs.in Crores)
| Metric | Value |
|---|---|
| Market Cap | ₹1,837 Cr. |
| Current Price | ₹692 |
| High / Low | ₹725 / ₹372 |
| Book Value | ₹34.8 |
| Dividend Yield | 0.15% |
| ROCE | -7.32% |
| ROE | -16.8% |
| Face Value | ₹10.0 |
Quarterly Results
The table displays quarterly financial results over several periods. Sales show a gradual increase from ₹33 crores in June 2021 to ₹56 crores in June 2024. Expenses also increased, rising from ₹29 crores to ₹58 crores over the same period. Operating profit fluctuated, with a notable drop to -₹1 crore in the last two quarters. The Operating Profit Margin (OPM) varied, ending negative. Other income remained low, while interest and depreciation costs grew. Profit before tax was mostly negative in recent quarters, leading to negative net profits and earnings per share (EPS) declining significantly, indicating worsening financial performance.
| Metric | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33 | 35 | 31 | 31 | 29 | 39 | 35 | 37 | 39 | 45 | 47 | 50 | 56 |
| Expenses | 29 | 31 | 26 | 31 | 28 | 34 | 35 | 36 | 37 | 41 | 44 | 51 | 58 |
| Operating Profit | 5 | 5 | 5 | 0 | 1 | 5 | 0 | 1 | 1 | 4 | 3 | -1 | -1 |
| OPM % | 15% | 14% | 16% | 0% | 5% | 12% | 0% | 3% | 3% | 10% | 7% | -3% | -2% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 3 | 5 | 5 | 7 | 8 |
| Profit Before Tax | 5 | 4 | 5 | -1 | -0 | 2 | -3 | -3 | -3 | -1 | -3 | -10 | -12 |
| Tax % | 26% | 26% | 26% | 1% | 119% | 58% | -4% | -15% | 1% | 49% | 7% | -27% | 5% |
| Net Profit | 3 | 3 | 3 | -1 | -1 | 1 | -3 | -3 | -3 | -2 | -3 | -7 | -13 |
| EPS in Rs | 1.37 | 1.28 | 1.33 | -0.40 | -0.33 | 0.36 | -1.28 | -1.05 | -1.13 | -0.64 | -1.14 | -2.68 | -4.79 |
About Zota Health Care
Zota Health Care founded in 2000, is a prominent Indian pharmaceutical company involved in drug development, manufacturing, and marketing. The company is known for producing high-quality medicines and strives to make healthcare affordable and accessible. Zota offers a wide range of products, including pharmaceuticals, nutraceuticals, and ayurvedic medicines, both in India and internationally.
Zota has expanded its reach through several strategic acquisitions of other brands, such as Sayona Medicare, Mexon Healthcare, and Vision Medlinks, which has helped it grow its product lineup and market presence. The company is listed on the National Stock Exchange of India and operates offices in Sri Lanka, Vietnam, and Nigeria.
The company places a strong emphasis on research and development to deliver innovative and effective healthcare solutions. Zota's goal is to enhance the well-being of people through its products and services. Its commitment to quality and continuous improvement has earned it recognition in the healthcare sector.
Zota Health Care Q1 Results - FAQs
1. What was Zota Health Care total revenue for Q1 of the fiscal year ending June 2024?
Zota Health Care reported a total revenue of ₹56.30 crores for Q1 of the fiscal year ending June 2024.
2. How did Zota Health Care total revenue in Q1 of June 2024 compare to the previous quarter?
Zota Health Caretotal revenue in Q1 of June 2024 increased by 13.43% compared to the previous quarter.
3. What was the percentage increase in Zota Health Care revenue compared to the same period last year?
Zota Health Care saw a 45.67% increase in revenue compared to the same period last year.
4. How much did Zota Health Care selling, general, and administrative expenses rise in Q1 of June 2024?
Zota Health Care selling, general, and administrative expenses rose by 34.12% from the previous quarter.
5. What was the operating loss reported by Zota Health Care for Q1 of June 2024?
Zota Health Carereported an operating loss of ₹9.28 crores for Q1 of June 2024.
6. How did Zota Health Care net income before taxes change in Q1 of June 2024?
Zota Health Carenet income before taxes worsened to a loss of ₹12.16 crores in Q1 of June 2024.
7. What was the diluted normalized EPS for Zota Health Care in Q1 of June 2024?
The diluted normalized EPS for Zota Health Care in Q1 of June 2024 was ₹-4.80.
8. How much revenue did Zota Health Care generate from operations in Q1 of June 2024?
Zota Health Caregenerated ₹5220.36 lakh from operations in Q1 of June 2024.
9. What was Zota Health Care profit before tax in Q1 of June 2024?
Zota Health Careprofit before tax was ₹232.21 lakh in Q1 of June 2024.
10. How did Zota Health Care profit for the period compare to the same quarter last year?
Zota Health Careprofit for the period increased significantly to ₹158.43 lakh from ₹21.22 lakh in the same quarter last year.
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.